Molecular Partners Aktie
4,90CHF | -0,25CHF | -4,85% |
WKN DE: A12DEH / ISIN: CH0256379097
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 89,49 |
BVF Partners LP | 10,93 |
Suvretta Capital Management LLC | 10,62 |
Novartis AG | 4,31 |
EcoR1 Capital, LLC | 2,69 |
Hansjörg Wyss | 2,67 |
GAM Investment Management (Switzerland) AG | 2,65 |
Michael Tobias Stumpp, PhD | 1,90 |
GAM Swiss Sustainable Companies | 1,26 |
UBAM - Swiss Equity | 0,89 |
GAM Multistock - Swiss Small & Mid Cap Equity | 0,73 |
UBS (CH) Equity Fund - Switzerland Sustainable (CHF) | 0,69 |
UBS (CH) Equity Fund - Small Caps Switzerland (CHF) | 0,59 |
Andreas Emmenegger, EMBA | 0,59 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 147 | 159 | 177 | 191 | 182 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,14 | 0,06 | 0,06 | 0,99 | 0,04 |
Bilanz (in Mio. CHF) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 100 | 178 | 164 | 255 | 192 |
Summe Anlagevermögen | 5 | 10 | 8 | 8 | 6 |
Summe Aktiva | 105 | 188 | 173 | 262 | 198 |
Bilanz (in Mio. CHF) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 3 | 7 | 6 | 5 | 4 |
Summe Fremdkapital | 51 | 80 | 65 | 27 | 22 |
Summe Eigenkapital | 54 | 107 | 107 | 235 | 176 |
Summe Passiva | 105 | 188 | 173 | 262 | 198 |
Adresse
Wagistrasse 14, 8952 Schlieren | |
Telefon | +41 (44) 755-77-00 |
Fax | +41 (44) 755-77-07 |
Internet | http://www.molecularpartners.com |
Management
Agnete Brunsvik Fredriksen
Independent Director |
Alexander Zürcher
Chief Operating Officer |
Anne Goubier
Senior VP-Research & Early Development |
Baris Arican
Vice President-Information Technology |
Daniel Steiner
Senior Vice President-Research & Technology |
Dominik Höchli
Independent Director |
Michael J. Vasconcelles
Independent Non-Executive Director |
Michael Pitzner
SVP-Legal, General Counsel & Compliance Officer |
Michael Tobias Stumpp
Executive Vice President-Projects |
Patrick Amstutz
Chief Executive Officer & Director |
Philippe Legenne
Chief Medical Officer |
Renate Gloggner
Executive VP-People, Community & Culture |
Robert Hendriks
Senior Vice President-Finance |
Sandipkumar S. Kapadia
Independent Director |
Seth D. Lewis
SVP-Investor Relations, Communications & Strategy |
Steven H. Holtzman
Independent Non-Executive Director |
Vito J Palombella
Independent Director |
William Matt Burns
Chairman |